Top compounds associated with response to CUL7


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA BRD-K13999467 CTRPv2 pan-cancer AAC -0.12 0.001
mRNA Bosutinib CTRPv2 pan-cancer AAC -0.11 0.001
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.002
mRNA BAY 61-3606 GDSC1000 pan-cancer AAC 0.11 0.002
mRNA valdecoxib CTRPv2 pan-cancer AAC -0.11 0.002
mRNA Lisitinib GDSC1000 pan-cancer AAC 0.11 0.002
mRNA CD-437 CTRPv2 pan-cancer AAC -0.1 0.002
mRNA Irinotecan gCSI pan-cancer AAC -0.17 0.002
mRNA FH535 GDSC1000 pan-cancer AAC 0.11 0.002
Download CSV